Close this search box.

Sanofi and PARAXEL to study potential of wearables in clinical trials

Sanofi and PARAXEL are teaming up to study the effectiveness of wearables in clinical trials. The companies are keen to find out whether remotely collected patient data could result in an optimization of data collection and thus more meaningful results.
A recent Stanford study already showed that wristbands aren’t as accurate as most people think when measuring physical activity. The Sanofi and PARAXEL study could be a great addition to this study, aimed more at clinical research.

Sanofi is an international pharmaceutical company, which engages in the research and development, manufacturing and marketing of pharmaceutical drugs. It is also involved in research projects. PAREXEL is a consulting firm which conducts research for clients.

They are combining their clinical, regulatory, logistical and technical expertise in this trial, as well as their global presence. The objective is to demonstrate the relevance of data collected remotely and the overall feasibility of utilizing wearables in clinical trials.

Collecting data through wearables

Wearables are increasingly used in trials and research projects. They do have certain advantages, for instance making it easier for patients to participate in trials and creating more opportunities for decentralised trials. It could even replace or reduce the number of clinical assessments and/or on-site visits during clinical trials. This not only potentially reduces the burden on trial participants, it could also decrease trial costs.

It’s a way of conducting research that’s worth exploring more. It remains the question, however, how accurate these devices are and whether they can optimize study performance. The Sanofi-PARAXEL collaboration should offer more insight into these questions. In particular, the companies are examining how data collected from several wearable devices can be streamlined into a single, scalable data system to provide valuable insights.

Building on previous studies

PAREXEL recently launched Patient Sensor Solution pilot study, which facilitates the remote collection of patient data from multiple devices, including activity trackers and glucometers. It securely captures, transmits, stores, and visualizes the collected data. The Sanofi-PARAXEL study will build on this study.  

It will be interesting to see whether this study comes to the same conclusion regarding the accuracy of wearables as the Stanford University study. While it’s certainly a very interesting subject, which needs to be explored in this day and age, one shouldn’t forget that both Sanofi and PAREXEL do benefit from a positive result.

Wearables are a core component of Sanofi’s digital trials strategy, as stated by Lionel Bascles, Global Head of Clinical Sciences and Operations of Sanofi. And PAREXEL’s Patient Sensor Solution focusses on data collected through wearables and other devices. 


ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Innovation Adoption: How to Traverse The Valleys of Death
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Data protection-critical incidents resulting from human error are often rooted in stress, routine, negative attitudes toward IT, and deficits in employees' identification with the healthcare facility.
How cyberpsychology helps prevent human errors leading to data leaks
What technologies will enter our homes in a few months? ICT&health checked it out at the CES 2024.
CES 2024: Meet the exciting innovations for health and well-being
An article on a new study on e-health assessment tools
eHealth success lies at the intersection of technology, people, and organization
Unlocking the Future: Professor Sylvia Thun, a trailblazer in healthcare interoperability, discusses the crucial role of seamless data exchange in revolutionizing medicine and empowering individuals with comprehensive access to their health data.
Seamless data exchange will unlock the long-awaited benefits of digitalization
Follow us